Celestone Chronodose 3mg/ml +4mg/ml susp. inj. amp. 1st

MSD Intervet
Expiry date:

Solution for injection containing betamethasone.

More info

Celestone Chronodose 3 mg/ml 1x1ml

Each mL of Celestone Chronodose Injection contains betamethasone 5.7 mg, as betamethasone sodium phosphate 3.9 mg (in solution) and betamethasone acetate 3 mg (in suspension) in an aqueous vehicle.

Celestone Chronodose is an injectable preparation containing both soluble and slightly soluble esters of betamethasone that provides anti-inflammatory, anti-rheumatic and antiallergic effects in the treatment of corticosteroid-responsive disorders. Prompt therapeutic activity in conditions responsive to corticosteroids is initiated by betamethasone sodium phosphate, a soluble ester that is absorbed quickly into tissues after injection. Sustained activity is provided by betamethasone acetate, which is only slightly soluble and affords a repository for slow absorption. The combined rapid and depot actions of these forms of betamethasone facilitate rapid control as well as steady maintenance of corticosteroid effects.

More Information
Nr. CNK0105700
Registration number Human
Brand MSD Intervet
Chilled No
Active Ingredient Betamethasone
Target species Human
Batch S036302
Expiry date Feb 1, 2021
Units per outer box 0
Ingredients Betamethasone
© 2020 Grovet B.V. All rights reserved.